+1 (704) 266-3234

Global Monoclonal Antibody Therapeutics Market Size, Status And Forecast 2022

Published on: Sep 2017 | From USD $3300 | Published By: QY RESEARCH | Number Of Pages: 106

This report studies the global Monoclonal Antibody Therapeutics market, analyzes and researches the Monoclonal Antibody Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Bayer
F. Hoffmann-La Roche
Pfizer
Sanofi
GlaxoSmithKline
Merck
Novartis
AbbVie
Amgen
Johnson & Johnson
Bristol-Myers Squibb Company
Biogen

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Monoclonal Antibody Therapeutics can be split into
Humanized Antibody
Human Mouse Chimeric Antibody

Market segment by Application, Monoclonal Antibody Therapeutics can be split into
Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Ophthalmological Diseases
Others

If you have any special requirements, please let us know and we will offer you the report as you want.


Table of Contents

Global Monoclonal Antibody Therapeutics Market Size, Status and Forecast 2022
1 Industry Overview of Monoclonal Antibody Therapeutics
1.1 Monoclonal Antibody Therapeutics Market Overview
1.1.1 Monoclonal Antibody Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Monoclonal Antibody Therapeutics Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Monoclonal Antibody Therapeutics Market by Type
1.3.1 Humanized Antibody
1.3.2 Human Mouse Chimeric Antibody
1.4 Monoclonal Antibody Therapeutics Market by End Users/Application
1.4.1 Cancer
1.4.2 Autoimmune Diseases
1.4.3 Infection
1.4.4 Hematological Diseases
1.4.5 Ophthalmological Diseases
1.4.6 Others

2 Global Monoclonal Antibody Therapeutics Competition Analysis by Players
2.1 Monoclonal Antibody Therapeutics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Bayer
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 F. Hoffmann-La Roche
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Pfizer
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Sanofi
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 GlaxoSmithKline
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Merck
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Novartis
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 AbbVie
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Amgen
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Johnson & Johnson
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Bristol-Myers Squibb Company
3.12 Biogen

4 Global Monoclonal Antibody Therapeutics Market Size by Type and Application (2012-2017)
4.1 Global Monoclonal Antibody Therapeutics Market Size by Type (2012-2017)
4.2 Global Monoclonal Antibody Therapeutics Market Size by Application (2012-2017)
4.3 Potential Application of Monoclonal Antibody Therapeutics in Future
4.4 Top Consumer/End Users of Monoclonal Antibody Therapeutics

5 United States Monoclonal Antibody Therapeutics Development Status and Outlook
5.1 United States Monoclonal Antibody Therapeutics Market Size (2012-2017)
5.2 United States Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2016 and 2017)

6 EU Monoclonal Antibody Therapeutics Development Status and Outlook
6.1 EU Monoclonal Antibody Therapeutics Market Size (2012-2017)
6.2 EU Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2016 and 2017)

7 Japan Monoclonal Antibody Therapeutics Development Status and Outlook
7.1 Japan Monoclonal Antibody Therapeutics Market Size (2012-2017)
7.2 Japan Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2016 and 2017)

8 China Monoclonal Antibody Therapeutics Development Status and Outlook
8.1 China Monoclonal Antibody Therapeutics Market Size (2012-2017)
8.2 China Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2016 and 2017)

9 India Monoclonal Antibody Therapeutics Development Status and Outlook
9.1 India Monoclonal Antibody Therapeutics Market Size (2012-2017)
9.2 India Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Monoclonal Antibody Therapeutics Development Status and Outlook
10.1 Southeast Asia Monoclonal Antibody Therapeutics Market Size (2012-2017)
10.2 Southeast Asia Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Monoclonal Antibody Therapeutics Market Size (Value) by Regions (2017-2022)
11.1.1 United States Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
11.1.2 EU Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
11.1.3 Japan Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
11.1.4 China Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
11.1.5 India Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
11.2 Global Monoclonal Antibody Therapeutics Market Size (Value) by Type (2017-2022)
11.3 Global Monoclonal Antibody Therapeutics Market Size by Application (2017-2022)

12 Monoclonal Antibody Therapeutics Market Dynamics
12.1 Monoclonal Antibody Therapeutics Market Opportunities
12.2 Monoclonal Antibody Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Monoclonal Antibody Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Monoclonal Antibody Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source


List of Tables and Figures

Figure Monoclonal Antibody Therapeutics Product Scope
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) (2012-2017)
Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Monoclonal Antibody Therapeutics Market Share by Regions in 2016
Figure United States Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Monoclonal Antibody Therapeutics Market Share by Type in 2016
Figure Humanized Antibody Market Size (Million USD) and Growth Rate (2012-2017)
Figure Human Mouse Chimeric Antibody Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Monoclonal Antibody Therapeutics Market Share by Application in 2016
Table Key Downstream Customer in Cancer
Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Cancer (2012-2017)
Table Key Downstream Customer in Autoimmune Diseases
Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Autoimmune Diseases (2012-2017)
Table Key Downstream Customer in Infection
Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Infection (2012-2017)
Table Key Downstream Customer in Hematological Diseases
Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Hematological Diseases (2012-2017)
Table Key Downstream Customer in Ophthalmological Diseases
Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Ophthalmological Diseases (2012-2017)
Table Key Downstream Customer in Others
Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Others (2012-2017)
Table Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2016 and 2017)
Figure Monoclonal Antibody Therapeutics Market Size Share by Players in 2016
Figure Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
Table Bayer Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Bayer (2012-2017)
Figure Bayer Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table F. Hoffmann-La Roche Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of F. Hoffmann-La Roche (2012-2017)
Figure F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table Pfizer Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table GlaxoSmithKline Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of GlaxoSmithKline (2012-2017)
Figure GlaxoSmithKline Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table AbbVie Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of AbbVie (2012-2017)
Figure AbbVie Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table Amgen Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Amgen (2012-2017)
Figure Amgen Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table Johnson & Johnson Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table Bristol-Myers Squibb Company Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Bristol-Myers Squibb Company (2012-2017)
Figure Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table Biogen Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Biogen (2012-2017)
Figure Biogen Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Type (2012-2017)
Figure Global Monoclonal Antibody Therapeutics Market Size Share by Type in 2012
Figure Global Monoclonal Antibody Therapeutics Market Size Share by Type in 2013
Figure Global Monoclonal Antibody Therapeutics Market Size Share by Type in 2014
Figure Global Monoclonal Antibody Therapeutics Market Size Share by Type in 2015
Figure Global Monoclonal Antibody Therapeutics Market Size Share by Type in 2016
Figure Global Monoclonal Antibody Therapeutics Market Size Share by Type in 2017
Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application (2012-2017)
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2012
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2013
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2014
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2016
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Monoclonal Antibody Therapeutics
Figure United States Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure United States Monoclonal Antibody Therapeutics Market Size Share by Players in 2016
Figure United States Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
Figure EU Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure EU Monoclonal Antibody Therapeutics Market Size Share by Players in 2016
Figure EU Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
Figure Japan Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Japan Monoclonal Antibody Therapeutics Market Size Share by Players in 2016
Figure Japan Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
Figure China Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure China Monoclonal Antibody Therapeutics Market Size Share by Players in 2016
Figure China Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
Figure India Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure India Monoclonal Antibody Therapeutics Market Size Share by Players in 2016
Figure India Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
Figure Southeast Asia Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Monoclonal Antibody Therapeutics Market Size Share by Players in 2016
Figure Southeast Asia Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Regions (2017-2022)
Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Regions (2017-2022)
Figure Global Monoclonal Antibody Therapeutics Market Size Share by Regions in 2017
Figure Global Monoclonal Antibody Therapeutics Market Size Share by Regions in 2022
Figure United States Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Type (2017-2022)
Figure Global Monoclonal Antibody Therapeutics Market Size Share by Type in 2017
Figure Global Monoclonal Antibody Therapeutics Market Size Share by Type in 2022
Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application (2017-2022)
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2017
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2022

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3300
USD $4300
USD $6600
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.